Companies Widen their Consumer Base in Wound Cleanser Product Market

31 Aug 2017

Advances in wound management products are noted to be an expanding industry with opportunities designed for the treatment of both acute and chronic wounds. Many of the technological advancements in wound care management are concentrated across innovations in advanced wound dressings, wound care saline products, and non-invasive wound care devices. However, recent economic slowdown has asserted that an immediate growth cannot be anticipated for all the developing nations across the globe. For example, economic slowdown in Russia and Brazil requires persistent and operational investment in healthcare infrastructure and improving political, economic, and legal healthcare framework. The growth in these geographies also demand rise in acceptance levels to free float of advanced and innovative technologies which are the key drivers of the wound Cleansers market growth.

Key players in the global wound cleanser products market are vying for partnerships and collaborations to expand their business and establish a strong hold on the market. In a recent development, APR Applied Pharma Research s.a. – Swiss, independent developer of science driven and patent protected healthcare products, announced in a press release that it has entered into a new strategic partnership with Aghraas-Cigalah – a leading Middle East pharmaceutical company – to commercialize the innovative wound cleanser Nexodyn® AcidOxidizing Solution (AOS) in United Arab Emirates, Saudi Arabia, Qatar, Omar, Kuwait and Barhain. After the successful agreements with Angelini in Italy and US and the Renhe Group in China, this step will certainly help the company to expand its reach on a global scale.

Strengthening their partnership further, Angelini and APR Applied Pharma Research launched Nexodyn in the USA. Angelini made this announcement in its press release, stating “The new Nexodyn AOS wound care solution, cleared for sale by the FDA, is now starting to be available in the USA, promoted and commercialized by the Italian pharmaceutical company Angelini, as a result of an exclusive partnership with the Swiss company APR Applied Pharma Research, the owner and developer of the proprietary, patented technology TEHCLO, for the production of acidic super-oxidizing solutions.”

Acknowledging the attractiveness of the wound cleanser market and opportunities in the nascent market, BIS Healthcare has compiled a market report titled ‘Global Wound Cleanser Products Market - Analysis & Forecasts, 2016-2023’, which is a meticulous study of the global wound cleanser products market, divided along the lines of Product type, Wound type, End-Users and different Regions, in order to gain a holistic view of the entire market. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps to form well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the global wound cleansers market. These include market drivers and restraints, market share analysis, competitive landscaping, Porter’s five forces, and key developments, among others.

This report includes the company profiles of major key players in the market that allows the readers to get an insight into the various industry trends. The leading companies profiled in the report are 3M Healthcare, B. Braun Medical Inc., Hollister Wound Care, Smith & Nephew plc, Derma Sciences Inc., Medline Industries, and Angelini Pharma, among others.


Twitter Feeds